MIR-9-1 ABERRANT METHYLATION IS A FREQUENT EVENT IN BREAST CANCER AND IS ASSOCIATED WITH BONE METASTASES

by Anca Florescu
Published 2012-10-01

STUDY OF MIR-200C AND MIR-9 METHYLATION ON PATIENTS WITH BREAST CANCER

by Anca Florescu, Dumitru Cojocaru, V. M. FAZIO, Paola Parrella
Published 2012-03-01

Evaluation of HER-2 expression in digestive system cancer

by Mihaela Tica, Liliana Dumitru, Adriana Dumitru, Mihaela Poparda, Crenguta Serboiu, Anca Florescu, Elena Ionica, Valeria Tica
Published 2010-06-01

Rheumatic Immune-Related Adverse Events—A Consequence of Immune Checkpoint Inhibitor Therapy

by Anca Bobircă, Florin Bobircă, Ioan Ancuta, Alesandra Florescu, Vlad Pădureanu, Dan Nicolae Florescu, Rodica Pădureanu, Anca Florescu, Anca Emanuela Mușetescu
Published 2021-06-01